13
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Pertussigen Treatment Retards, but fails to Prevent, the Development of type I, Insulin-Dependent Diabetes Mellitus (IDDM) in NOD Mice

, &
Pages 311-317 | Received 18 Jan 1991, Published online: 07 Jul 2009

References

  • Cahill G F, McDevitt H O. Insulin‐dependent diabetes mellitus: the initial lesion. New Engl J Med. 1981; 304: 1454–1465
  • Eisenbarth G S. Type I diabetes mellitus. a chromic autoimmune disease. New Engl J Med. 1986; 314: 1360–1368
  • Cudworth A G, Wolf E. The genetic susceptibility to Type I (insulin‐dependent) diabetes mellitus. Clin Endocrin Metab. 1982; 11: 389–408
  • Maclaren N K, Rosenbloom A L, McLaughlin J V, Krupp B, Ruck E, Lezotte D. HLA in insulin dependent diabetes mellitus (IDDM): dominant susceptibility plus heterogeneity. IRCS Med Sci. 1981; 9: 631
  • Colle E, Guttmann R D, Seemayer T. Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex. J Exp Med. 1981; 154: 1237–1242
  • Buse J B, Chaplin D D, Ben‐nun A, Klein K A, Eisenbarth G S, Seidman J O, Jackson R A. Class I, II and III major histocom‐patibility complex gene polymorphisms in BB rats. Diabetologia. 1984; 27: 77–79
  • Makino S, Muraoka Y, Kishimoto Y, Hayashi Y. Genetic analysis of insulitis in NOD mice. Exp Animals. 1985; 34: 425–432
  • Hattori M, Buse J B, Jackson R A, Glimcher L, Dorf M E, Minami M, Makino S, Moriwaki K, Kuzuya H, Imura H, Strauss W M, Seidman J G, Eisenbarth G S. The NOD mouse: Recessive diabetogenic gene in the major histocompatibility complex. Science 1986; 231: 733–735
  • Prochazka M, Leiter E H, Serreze D V, Coleman D L. Three recessive loci required for insulin‐dependent diabetes in non‐obese diabetic mice. Science 1987; 237: 286–289
  • Wicker L S, Miller B J, Coker L Z, McNally S E, Scott S, Mullen Y, Appel M C. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med. 1987; 165: 1639–1654
  • Makino S, Kunimoto K, Muraeoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non‐obese, diabetic strain of mice. Exp Animals. 1980; 29: 1–13
  • Fujino‐Kurihara H, Fujita H, Hakura A, Nonaka K, Tarui S. Morphological aspects on pancreatic islets of non‐obese diabetic (NOD) mice. Virchow Arch Cell Path. 1986; 49: 107–120
  • Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 1965; 14: 619–633
  • Harada M, Makino S. Immunological manipulation of diabetes production in NOD mice. Insulitis and Type I Diabetes: Lessons From the NOD Mouse, S Tauri, Y Tochino, K Nonaka. Academic Press, Inc, Orlando 1986; 143–153
  • Hanafus T, Nonaka K, Tarui S. Immune pathogenesis of the NOD mouse: an overview. Insulitis and Type I Diabetes: Lessons From the NOD Mouse, S Tauri, Y Tochino, K Nonaka. Academic Press, Inc, Orlando 1986; 75–82
  • Ogawa M, Maruyama T, Hasegawa T, Kanaya T, Kobayashi Y, Tochino Y, Uda H. Biomed Res. 1986; 6: 103
  • Koike T, Itoh Y, Ishii T, Ito I, Takabayashi K, Maruyama N, Tomioka H, Yosida S. Preventive effect of monoclonal anti‐L3T4 antibody on development of diabetes in NOD mice. Diabetes. 1986; 36: 539–541
  • Toyota T, Satoh J, Oya K, Shintani S, Okano T. Streptococcal preparation (OK‐432) inhibits development of Type I diabetes in NOD mice. Diabetes. 1986; 35: 496–499
  • Ikehara S, Ohtsuki H, Good R A, Asamoto H, Nakamura T, Sekita K, Muso E, Tochino Y, Ida T, Kuzuya H, Imura H, Hamashima Y. Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. PNAS. 1985; 82: 7743–7747
  • Ikehara S, Nakamura T, Sekita K, Muso E, Yasumizu R, Ohtsuki H, Hamashima Y, Good R A. Treatment of systemic and organ‐specific autoimmune disease in mice by allogeneic bone marrow transplantation. Prog Clin Biol Res. 1987; 229: 131–146
  • LaFace D M, Peck A B. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes‐nonsusceptible mice associated with transfer and prevention of autoimmune diabetes. Diabetes. 1989; 38: 894–901
  • Rubenstein A H, Pyke D. Immunosuppression in the treatment of insulin‐dependent (Type I) diabetes. Lancet. 1987; i: 436–437
  • Herold K C, Rubenstein A H. Immunosuppression for insulin‐dependent diabetes. New Engl J Med. 1988; 318: 701–703
  • Munoz J J. Biological activities of pertussigen. The Pertussis Toxin, R D Sekura, J Moss, M Vaughn. Academic Press, Orlando 1985; 1–18
  • Huang S ‐W, Taylor G E. Pertussis vaccine inhibits immune insulitis. Clin Ex Immunol. 1982; 48: 375–380
  • Huang S ‐W, Taylor G E, Basid A. The effect of pertussigen vaccine on the insulin‐dependent diabetes induced by streptozotocin in mice. Ped Res. 1984; 18: 221–226
  • Huang S ‐W. Enhancement of suppressor T cell activity by lymphocyte promoting factor of Bordetella pertussis. Immunopharm. Immunotox. 1990, in press

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.